Capital International Inc. CA Has $151,000 Stake in Aetna Inc (AET)
Capital International Inc. CA lessened its holdings in shares of Aetna Inc (NYSE:AET) by 29.6% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 950 shares of the company’s stock after selling 400 shares during the period. Capital International Inc. CA’s holdings in Aetna were worth $151,000 at the end of the most recent quarter.
Several other institutional investors and hedge funds have also modified their holdings of AET. Wells Fargo & Company MN lifted its stake in Aetna by 4.2% in the 3rd quarter. Wells Fargo & Company MN now owns 1,365,596 shares of the company’s stock worth $217,144,000 after purchasing an additional 54,928 shares in the last quarter. State of Tennessee Treasury Department raised its position in shares of Aetna by 26.3% during the 2nd quarter. State of Tennessee Treasury Department now owns 557,814 shares of the company’s stock valued at $84,692,000 after buying an additional 116,280 shares during the period. Fayez Sarofim & Co. raised its position in shares of Aetna by 82.8% during the 3rd quarter. Fayez Sarofim & Co. now owns 7,427 shares of the company’s stock valued at $1,181,000 after buying an additional 3,365 shares during the period. Banque Pictet & Cie SA purchased a new stake in shares of Aetna during the 2nd quarter valued at approximately $10,567,000. Finally, Pictet & Cie Europe SA purchased a new stake in Aetna in the second quarter valued at approximately $2,269,000. Hedge funds and other institutional investors own 88.03% of the company’s stock.
Aetna Inc (AET) traded up $3.90 during midday trading on Friday, hitting $182.73. 4,315,773 shares of the stock traded hands, compared to its average volume of 3,977,818. Aetna Inc has a 1-year low of $116.04 and a 1-year high of $192.37. The company has a debt-to-equity ratio of 0.52, a current ratio of 0.53 and a quick ratio of 0.53. The firm has a market cap of $59,601.41, a price-to-earnings ratio of 17.90, a PEG ratio of 1.67 and a beta of 0.61.
The firm also recently announced a quarterly dividend, which will be paid on Friday, January 26th. Investors of record on Thursday, January 11th will be issued a $0.50 dividend. The ex-dividend date of this dividend is Wednesday, January 10th. This represents a $2.00 dividend on an annualized basis and a dividend yield of 1.09%. Aetna’s payout ratio is currently 37.04%.
A number of analysts have issued reports on the company. Cantor Fitzgerald reissued a “neutral” rating and issued a $175.00 target price on shares of Aetna in a research report on Monday, October 23rd. Citigroup boosted their price target on shares of Aetna from $183.00 to $197.00 and gave the stock a “buy” rating in a research note on Thursday, November 2nd. BMO Capital Markets boosted their target price on shares of Aetna from $175.00 to $200.00 and gave the stock a “market perform” rating in a research note on Friday, October 27th. Zacks Investment Research downgraded shares of Aetna from a “buy” rating to a “hold” rating in a research note on Tuesday, October 3rd. Finally, Argus reiterated a “buy” rating and set a $185.00 target price (up previously from $165.00) on shares of Aetna in a research note on Tuesday, September 12th. Twelve equities research analysts have rated the stock with a hold rating and fourteen have assigned a buy rating to the company. Aetna has an average rating of “Buy” and an average target price of $175.19.
In related news, EVP Margaret M. Mccarthy sold 10,288 shares of the business’s stock in a transaction that occurred on Friday, September 15th. The shares were sold at an average price of $162.85, for a total transaction of $1,675,400.80. Following the transaction, the executive vice president now directly owns 33,563 shares of the company’s stock, valued at $5,465,734.55. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, President Karen S. Lynch sold 15,271 shares of the business’s stock in a transaction that occurred on Monday, September 18th. The shares were sold at an average price of $161.91, for a total transaction of $2,472,527.61. Following the transaction, the president now directly owns 64,261 shares in the company, valued at $10,404,498.51. The disclosure for this sale can be found here. 0.90% of the stock is owned by insiders.
Aetna Inc is a diversified healthcare benefits company. The Company operates through three segments: Health Care, Group Insurance and Large Case Pensions. It offers a range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental, behavioral health, group life and disability plans, medical management capabilities, Medicaid healthcare management services, Medicare Advantage and Medicare Supplement plans, workers’ compensation administrative services and health information technology (HIT) products and services.
Want to see what other hedge funds are holding AET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Aetna Inc (NYSE:AET).
Receive News & Ratings for Aetna Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aetna Inc and related companies with MarketBeat.com's FREE daily email newsletter.